BioPike to Distribute AnaSpec Products in China

Mar 12, 2009

NEW YORK (GenomeWeb News) – BioPike has inked a non-exclusive agreement to distribute AnaSpec's catalog and custom products in China, the companies announced yesterday.

The move will increase the availability of AnaSpec's integrated proteomics tools in China, as BioPike distributes scientific products across China and serves more than 3,000 customers and 300 national key laboratories.

AnaSpec specializes in peptides, detection reagents, and combinatorial chemistry products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

All So Similar

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A Very Long Time Ago Indeed

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

This Week in PNAS

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Genetic Condition to Drug Inspiration

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Featured White Papers

xMAP Cookbook: A collection of methods and protocols for developing multiplex assays with xMAP Technology

Stroma Liquid Biopsy - Biomarkers of the Dysregulation of the Serum Proteome in Cancer

Cleanascite Lipid Removal & Clarification Reference Applications

Albumin Removal Reference Applications

Aug

23

Featured Webinar

Automated High-Throughput Protein Production of Human Proteins and Antibodies

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.

Oct

10

Featured Webinar

Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Main menu